YW, look at renovocyte site, I believe they will serve as entest's stem cell processing site. Renovocyte is currently providing the study free of charge.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.